The histology and cytology market is estimated to reach US $ 39.07 billion by 2030 from a market value of US $ 16.10 billion in 2022 and is expected to grow at a CAGR of 13.5% during the 2022-2030 forecast period. I am.
Histology and cytology are scientific specialists involved in the diagnosis of diseases and other conditions. Histology is the study of microscopic anatomy of cells and human tissue, including structure and function. Cytology, on the other hand, is a branch of life science and is emphasized in the study of human cells in terms of function, structure and chemistry. Relevant tests are performed by placing contaminated tissue or cell samples in an electron microscope or light microscope. This allows scientists to examine the microscopic anatomy of the sample.
Increasing prevalence of cancer and technological advances in diagnostic and molecular technology are key drivers of the growth of the histology and cytology markets. Increasing standardization of pathological laboratories and favorable reimbursement for cancer screening and laboratory tests have also contributed to the growth of the histology and cytology markets during the forecast period. According to the International Agency for Research on Cancer (IARC), there were approximately 17 million new cancer cases worldwide and 9.5 million cancer deaths registered in 2018. In addition, the global burden of cancer is expected to increase to approximately 27.5 million new cancer cases and 16.3 million cancer deaths by 2040. This is accelerating the demand for histology and cytology and is expected to contribute to the growth of the global histology and cytology market. However, safety and diagnostic accuracy issues, and the lack of public awareness of diagnostic tests, may impede the growth of the histology and cytology markets during the 2022-2030 forecast period.
Histology and Cytology Market Segment
The histology and cytology market is divided by test type (histology, cytology), product (equipment and analysis software system, consumables and reagents), end user (life science, clinical diagnostics), and region. Will be done. These segments are further subsegmented based on a variety of factors and consist of some additional information about the market, such as the combined annual growth rate of each segment and subsegment, the market value and volume of the valuation period.
Regional overview of the histology and cytology market
The histology and cytology markets are further subdivided based on region and the market growth of each country is evaluated. These include North America (US, Canada, and other North America), Europe (Germany, France, Italy, Spain, UK, and other Europe), Asia Pacific (China, Japan, India, Australia, Singapore, and others). Asia Pacific) and other regions.
North America is the world’s leading region in terms of market share. This is due to the increased incidence of cancer, favorable government reimbursement policies, and the availability of advanced medical infrastructure in the region. Meanwhile, the Asia Pacific histology and cytology markets are expected to show the highest growth rate / CAGR during the 2022-2030 forecast period. This is due to an increase in the elderly population, increased incidence of cancer, and increased awareness of cancer screening in developing countries such as India and China.
A key player in the histology and cytology market
Key players in the histology and cytology market include Hologic, Inc., F. Hoffmann-La Roche Ltd., Abbott Laboratories, Becton, Dickinson & Company, Danaher Corporation, Merck KGaA, Thermo Fisher Scientific, Inc., These include Sysmex Corporation, Trivitron Healthcare and Koninklijke Philips NV. The study includes a detailed competitive analysis of these leading companies in the histology and cytology markets, corporate profiles, recent developments, and key market strategies.